Original Article

The Role and Function of Secretory Protein Matrix Metalloproteinase-3 (MMP3) in Cervical Cancer

Abstract

Background: We started with RNA-seq analysis and aimed to investigate the possibility of secretory protein matrix metalloproteinase-3(MMP3) as a new diagnosis and therapeutic target in cervical cancer.

Methods: The study was conducted on Nov 2021 at the Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China. Through conjoint analysis of gene expression data as well as survival rate data, we explored the potential secretary proteins associated with cervical cancer carcinogenesis. One hundred patients aged 38-72 years with clinical stage I-IV cervical cancer, and 100 age-matched healthy women were included. The expression changes in serum of clinical patients was detected. We knockdown or overexpressed the secretory proteins then explored its influence on biological function of cervical cancer cells.

Results: By cross-analysis of The Cancer Genome Atlas (TCGA) database and MetazSecKB database, MMP3 gene was most significantly upregulated in cervical cancer patients (P < 0.05). Furthermore, MMP3 protein was remarkably increased in the serum of clinical cervical cancer patients and decreased after receiving treatment. Overexpression of MMP3 in HT-3 cells or culturing new cells using the supernatant of the medium after MMP3 overexpression could increase cell viability (P < 0.05) as well as proliferation (P < 0.05). Knockdown of MMP3 reduced the phosphorylation of PI3K as well as AKT proteins, while the PI3K phosphorylation inhibitors could suppress the impact of MMP3 on increasing cell proliferation as well as viability.

Conclusion: MMP3 could be an underlying target for early diagnosis and treat cervical cancer in the future.

1. Ventriglia J, Paciolla I, Pisano C, et al (2017). Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives. Cancer Treat Rev, 59:109-116.
2. Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK (2020). Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis, 37(1):107-113.
3. Niranjan R, Kishor S, Kumar A (2021). Matrix metalloproteinases in the pathogenesis of dengue virus disease: involvement of immune system and newer therapeutic strategies. J Med Virol, 93(8):4629-4637.
4. Werle MJ, VanSaun M (2003). Activity dependent removal of agrin from synaptic basal lamina by matrix metalloproteinase 3. J Neurocytol, 32(5-8):905-13.
5. Shorning BY, Dass MS, Smalley MJ, Pearson HB (2020). The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int J Mol Sci, 21(12):4507.
6. Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X (2019). Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer, 18(1):26.
7. Nagase H, Visse R, Murphy G (2006). Murphy Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res, 69(3):562-73.
8. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T, Sugimachi K (1995). Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer, 75(6 Suppl):1516-9.
9. Newell KJ, Witty JP, Rodgers WH, Matrisian LM (1994). Matrisian Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog, 10(4):199-206.
10. Uría JA, Ståhle-Bäckdahl M, Seiki M, Fueyo A, López-Otín C (1997). Lopez-Otin Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res, 57(21):4882-8.
11. Höyhtyä M, Fridman R, Komarek D, et al (1994). Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer, 56(4):500-5.
12. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, et al (1996). Expression and localization of 92kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis, 14(1):12-8.
13. Gobin E, Bagwell K, Wagner J, et al (2019). A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer, 19(1):581.
14. Huang JF, Du WX, Chen JJ (2016). Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis. J BUON, 21(1):235-43.
15. Hagemann T, Bozanovic T, Hooper S, et al (2007). Molecular profiling of cervical cancer progression. Br J Cancer, 96(2):321-8.
16. Mendes O, Kim HT, Stoica G (2005). Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis, 22(3):237-46.
17. Chu C, Liu X, Bai X, et al (2018). MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3. Int J Biol Sci, 14(2):228-236.
18. Sternlicht MD, Lochter A, Sympson CJ, et al (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98(2):137-46.
19. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ (1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 139(7):1861-72.
20. Radisky DC, Levy DD, Littlepage LE, et al (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436(7047):123-7.
21. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000). Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol, 18(5):1135-49.
22. Taha EA, Sogawa C, Okusha Y, et al (2020). Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles. Cancers (Basel), 12(5):1260.
23. Ye J, Gao M, Guo X, Zhang H, Jiang F (2020). Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway. Biomed Pharmacother, 2020;127:110223.
24. Chen H, Zhou L, Wu X, et al (2016). The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed), 21(5), 1084–1091.
25. Li GC, Qin XL, Song HH, et al (2019). Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3. J Cell Physiol, 234(12):22331-22342.
26. Pei XD, He ZL, Yao HL, et al (2021). 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. Eur J Nutr, 60(5):2781-2793.
Files
IssueVol 53 No 4 (2024) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v53i4.15562
Keywords
Cervical cancer Diagnosis Matrix metalloproteinase-3
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Shao L, Liu W, Zhang C, Ma W, Yu X, Han J, Wang X. The Role and Function of Secretory Protein Matrix Metalloproteinase-3 (MMP3) in Cervical Cancer. Iran J Public Health. 2024;53(4):855-866.